India’s emerging True MRP generic pharmacy network expands rapidly since its November 2024 launch, targeting 10,000 outlets by 2031 ...
Corporate history is replete with examples of the ‘third generation curse’, but the Daftary family seem to be bucking that ...
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it has signed a non-exclusive license agreement ...
A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extolled the benefits of the QR barcoding programme ...
For much of the past two decades, global biotech leadership has clustered around a handful of hubs, each anchored by patient ...
Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin ...
Shilpa Biologicals, an integrated biologics development and manufacturing organisation, announces an exclusive Middle East ...
The conversation around environmental sustainability in the pharma industry is now expanding beyond the traditional ...
The injectable pharma landscape is becoming increasingly interconnected, with pharma companies, CDMOs, device manufacturers ...
Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (“CDMO”), announced that it is now manufacturing Fayuvi (rebisufligene ...
Congress 2026, AstraZeneca presented the design of the Phase IIb PRESTO trial, a large study set to evaluate whether AZD6793, ...
Oncodesign Services and Nexus BioQuest have formed a partnership connecting their respective in vitro and in vivo expertise, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results